Vyne Therapeutics Inc
NASDAQ:VYNE
Vyne Therapeutics Inc
NASDAQ:VYNE
Price:
0.6161
USD
1.9%
Market Closed
Market Cap:
$20.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Vyne Therapeutics Inc
NASDAQ:VYNE
|
US |
|
Enertime SAS
PAR:ALENE
|
FR |
|
InterContinental Hotels Group PLC
LSE:IHG
|
UK |
|
Smart Parking Ltd
ASX:SPZ
|
AU |
|
Industrial & Infrastructure Fund Investment Corp
TSE:3249
|
JP |
|
Leeku Industrial Co Ltd
KRX:025820
|
KR |
|
Capital Bancorp Inc
NASDAQ:CBNK
|
US |
|
H
|
HBX Group International PLC
MAD:HBX
|
UK |
|
Kaleido Biosciences Inc
OTC:KLDO
|
US |
|
A
|
Arizon RFID Technology Cayman Co Ltd
TWSE:6863
|
KY |
|
Domino's Pizza Group PLC
LSE:DOM
|
UK |
|
W
|
Wooree E&L Co Ltd
KOSDAQ:153490
|
KR |
|
K
|
Kleannara Co Ltd
KRX:004540
|
KR |
|
Cleanaway Co Ltd
TWSE:8422
|
TW |
|
G
|
Glencore PLC
JSE:GLN
|
CH |
|
Acquazzurra SpA
MIL:ACQ
|
IT |
|
Saudi Tadawul Group Holding Company SJSC
SAU:1111
|
SA |
Balance Sheet
Balance Sheet Decomposition
Vyne Therapeutics Inc
Vyne Therapeutics Inc
Balance Sheet Decomposition is not available for
Vyne Therapeutics Inc
Vyne Therapeutics Inc
Balance Sheet
Vyne Therapeutics Inc
Vyne Therapeutics Inc
Currency: USD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
44
|
4
|
10
|
50
|
44
|
58
|
42
|
31
|
31
|
20
|
24
|
|
| Cash Equivalents |
44
|
4
|
10
|
50
|
44
|
58
|
42
|
31
|
31
|
20
|
24
|
|
| Short-Term Investments |
0
|
27
|
49
|
87
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
0
|
0
|
16
|
8
|
5
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
1
|
0
|
0
|
16
|
8
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
7
|
7
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
4
|
3
|
19
|
7
|
6
|
2
|
65
|
45
|
6
|
|
| Total Current Assets |
44
|
32
|
64
|
140
|
76
|
87
|
63
|
38
|
96
|
64
|
30
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
5
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
10
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
4
|
4
|
3
|
2
|
2
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
44
N/A
|
42
-4%
|
67
+59%
|
140
+109%
|
81
-42%
|
94
+15%
|
67
-28%
|
41
-39%
|
98
+139%
|
67
-32%
|
30
-55%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
1
|
2
|
3
|
3
|
19
|
5
|
7
|
2
|
2
|
3
|
1
|
|
| Accrued Liabilities |
0
|
1
|
3
|
6
|
5
|
12
|
9
|
4
|
4
|
9
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
2
|
2
|
0
|
6
|
5
|
3
|
3
|
2
|
3
|
0
|
|
| Total Current Liabilities |
1
|
4
|
8
|
10
|
29
|
22
|
18
|
9
|
8
|
15
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
33
|
33
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
9
|
7
|
0
|
2
|
1
|
0
|
0
|
1
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
13
+1 463%
|
15
+17%
|
10
-34%
|
64
+563%
|
56
-12%
|
18
-67%
|
9
-49%
|
9
-4%
|
15
+66%
|
2
-84%
|
|
| Equity | ||||||||||||
| Common Stock |
59
|
59
|
109
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
16
|
30
|
59
|
111
|
311
|
566
|
640
|
663
|
691
|
731
|
758
|
|
| Additional Paid In Capital |
0
|
1
|
2
|
241
|
328
|
604
|
688
|
694
|
780
|
783
|
785
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
43
N/A
|
30
-31%
|
52
+77%
|
130
+149%
|
18
-87%
|
38
+113%
|
49
+30%
|
31
-35%
|
89
+183%
|
52
-41%
|
28
-47%
|
|
| Total Liabilities & Equity |
44
N/A
|
42
-4%
|
67
+59%
|
140
+109%
|
81
-42%
|
94
+15%
|
67
-28%
|
41
-39%
|
98
+139%
|
67
-32%
|
30
-55%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
1
|
2
|
3
|
3
|
14
|
15
|
33
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
